Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

RBM8A antibody (AA 79-112)

RBM8A Reactivity: Mouse WB Host: Rabbit Polyclonal RB49687 unconjugated
Catalog No. ABIN6242599
  • Target See all RBM8A Antibodies
    RBM8A (RNA Binding Motif Protein 8A (RBM8A))
    Binding Specificity
    • 5
    • 4
    • 2
    • 1
    • 1
    • 1
    AA 79-112
    Reactivity
    • 32
    • 22
    • 18
    • 5
    • 5
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 1
    • 1
    Mouse
    Host
    • 31
    • 5
    Rabbit
    Clonality
    • 33
    • 4
    Polyclonal
    Conjugate
    • 19
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    This RBM8A antibody is un-conjugated
    Application
    • 19
    • 12
    • 9
    • 5
    • 4
    • 2
    • 2
    • 1
    Western Blotting (WB)
    Predicted Reactivity
    X, B, Rat
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogen
    This RBM8A antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 79-112amino acids from the Central region of human RBM8A.
    Clone
    RB49687
    Isotype
    Ig Fraction
    Top Product
    Discover our top product RBM8A Primary Antibody
  • Application Notes
    WB: 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Expiry Date
    6 months
  • Target
    RBM8A (RNA Binding Motif Protein 8A (RBM8A))
    Alternative Name
    RBM8A (RBM8A Products)
    Synonyms
    BOV-1A antibody, BOV-1B antibody, BOV-1C antibody, C1DELq21.1 antibody, DEL1q21.1 antibody, MDS014 antibody, RBM8 antibody, RBM8B antibody, TAR antibody, Y14 antibody, ZNRP antibody, ZRNP1 antibody, 2310057C03Rik antibody, AA673428 antibody, Rbm8 antibody, RBM8A antibody, rbm8 antibody, rbm8a antibody, rnp-5 antibody, fb34f03 antibody, wu:fb34f03 antibody, zgc:110525 antibody, rbm8-A antibody, rbm8a-A antibody, rbm8-B antibody, RNA binding motif protein 8A antibody, RNA binding motif protein 8a antibody, RNA binding motif protein 8A S homeolog antibody, RNA binding motif protein 8A L homeolog antibody, RBM8A antibody, Rbm8a antibody, rbm8a antibody, rbm8a.S antibody, rbm8a.L antibody
    Background
    Core component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junctions on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. The EJC marks the position of the exon-exon junction in the mature mRNA for the gene expression machinery and the core components remain bound to spliced mRNAs throughout all stages of mRNA metabolism thereby influencing downstream processes including nuclear mRNA export, subcellular mRNA localization, translation efficiency and nonsense-mediated mRNA decay (NMD). The MAGOH-RBM8A heterodimer inhibits the ATPase activity of EIF4A3, thereby trapping the ATP- bound EJC core onto spliced mRNA in a stable conformation. The MAGOH-RBM8A heterodimer interacts with the EJC key regulator WIBG/PYM leading to EJC disassembly in the cytoplasm and translation enhancement of EJC-bearing spliced mRNAs by recruiting them to the ribosomal 48S preinitiation complex. Its removal from cytoplasmic mRNAs requires translation initiation from EJC-bearing spliced mRNAs. Associates preferentially with mRNAs produced by splicing. Does not interact with pre-mRNAs, introns, or mRNAs produced from intronless cDNAs. Associates with both nuclear mRNAs and newly exported cytoplasmic mRNAs. The MAGOH-RBM8A heterodimer is a component of the nonsense mediated decay (NMD) pathway. Involved in the splicing modulation of BCL2L1/Bcl-X (and probably other apoptotic genes), specifically inhibits formation of proapoptotic isoforms such as Bcl-X(S), the function is different from the established EJC assembly.
    Molecular Weight
    19889
    UniProt
    Q9Y5S9
You are here:
Support